BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31054272)

  • 1. The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.
    Wang H; You G
    Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1293-1301. PubMed ID: 31054272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Protein Kinase A Stimulates SUMOylation, Expression, and Transport Activity of Organic Anion Transporter 3.
    Wang H; Zhang J; You G
    AAPS J; 2019 Feb; 21(2):30. PubMed ID: 30761470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide Hormone Insulin Regulates Function, Expression, and SUMOylation of Organic Anion Transporter 3.
    Zhang J; You G
    AAPS J; 2021 Mar; 23(2):41. PubMed ID: 33709304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topotecan and Ginkgolic Acid Inhibit the Expression and Transport Activity of Human Organic Anion Transporter 3 by Suppressing SUMOylation of the Transporter.
    Yu Z; You G
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Essential Role of Nedd4-2 in the Ubiquitination, Expression, and Function of Organic Anion Transporter-3.
    Xu D; Wang H; You G
    Mol Pharm; 2016 Feb; 13(2):621-30. PubMed ID: 26651153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
    Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
    Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
    Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
    Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.
    Kim EY; Chen L; Ma Y; Yu W; Chang J; Moskowitz IP; Wang J
    J Mol Cell Cardiol; 2012 Mar; 52(3):638-49. PubMed ID: 22155005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SENP2-mediated Akt deSUMOylation promotes cardiac regeneration via activating Akt pathway.
    Chen Y; Xu T; Li M; Li C; Ma Y; Chen G; Sun Y; Zheng H; Wu G; Liao W; Liao Y; Chen Y; Bin J
    Clin Sci (Lond); 2021 Mar; 135(6):811-828. PubMed ID: 33687053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.
    Xiao N; Li H; Yu W; Gu C; Fang H; Peng Y; Mao H; Fang Y; Ni W; Yao M
    FASEB J; 2019 Jan; 33(1):163-174. PubMed ID: 29969578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SENP2 regulates hepatocellular carcinoma cell growth by modulating the stability of β-catenin.
    Shen HJ; Zhu HY; Yang C; Ji F
    Asian Pac J Cancer Prev; 2012; 13(8):3583-7. PubMed ID: 23098437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels.
    Chen X; Zhang Y; Ren X; Su Q; Liu Y; Dang X; Qin Y; Yang X; Xing Z; Shen Y; Wang Y; Bai Z; Yeh ETH; Wu H; Qi Y
    J Biol Chem; 2021 Oct; 297(4):101183. PubMed ID: 34509475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
    Jiang M; Chiu SY; Hsu W
    Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO1/sentrin/SMT3 specific peptidase 2 modulates target molecules and its corresponding functions.
    Liu SL; Gao FH
    Biochimie; 2018 Sep; 152():6-13. PubMed ID: 29908207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
    Mirecka A; Morawiec Z; Wozniak K
    Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
    Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
    Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protease SENP2 controls hepatic gluconeogenesis by regulating the SUMOylation of the fuel sensor AMPKα.
    Dou X; Zhou WY; Ding M; Ma YJ; Yang QQ; Qian SW; Tang Y; Tang QQ; Liu Y
    J Biol Chem; 2022 Feb; 298(2):101544. PubMed ID: 34971706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An essential role of small ubiquitin-like modifier (SUMO)-specific Protease 2 in myostatin expression and myogenesis.
    Qi Y; Zuo Y; Yeh ET; Cheng J
    J Biol Chem; 2014 Feb; 289(6):3288-93. PubMed ID: 24344126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner.
    Lu H; Liu B; You S; Chen L; Dongmei Q; Gu M; Lu Y; Chen Y; Zhang F; Yu B
    Mol Biol Rep; 2013 Mar; 40(3):2485-90. PubMed ID: 23224591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.